Abbott Laboratories (ABT) Long-Term Investments (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Long-Term Investments data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 20.18% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 20.18% YoY), and the FY2025 full-year result was $918.0 million, up 3.61% from the prior year.
• Long-Term Investments climbed to $1.1 billion in Q1 2026, from $918.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $1.1 billion in Q1 2026 to a low of $734.0 million in Q2 2022.
• A 5-year average of $853.3 million and a median of $818.0 million in 2024 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments fell 8.82% in 2022 and advanced 20.18% in 2026, its largest moves.
• Tracing ABT's Long-Term Investments over 5 years: stood at $766.0 million in 2022, then grew by 4.31% to $799.0 million in 2023, then rose by 10.89% to $886.0 million in 2024, then grew by 3.61% to $918.0 million in 2025, then increased by 18.74% to $1.1 billion in 2026.
• Business Quant data shows ABT's Long-Term Investments at $1.1 billion in Q1 2026, $918.0 million in Q4 2025, and $951.0 million in Q3 2025.